Asset Management One Co. Ltd. cut its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 13.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 75,526 shares of the company’s stock after selling 11,655 shares during the quarter. Asset Management One Co. Ltd.’s holdings in HCA Healthcare were worth $22,848,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. FMR LLC boosted its holdings in HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Meritage Group LP bought a new position in HCA Healthcare during the 3rd quarter worth $150,548,000. Canoe Financial LP lifted its position in shares of HCA Healthcare by 226,952.9% during the 4th quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock valued at $69,513,000 after acquiring an additional 231,492 shares during the period. Holocene Advisors LP increased its position in shares of HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after purchasing an additional 208,015 shares during the period. Finally, Nordea Investment Management AB grew its stake in HCA Healthcare by 29.7% during the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after buying an additional 193,075 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.
Analyst Upgrades and Downgrades
HCA has been the topic of several analyst reports. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. TD Cowen dropped their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Oppenheimer boosted their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $385.67.
HCA Healthcare Trading Down 1.8 %
HCA opened at $316.18 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock has a market cap of $80.09 billion, a PE ratio of 14.39, a price-to-earnings-growth ratio of 1.11 and a beta of 1.64. The company has a fifty day moving average of $313.23 and a 200-day moving average of $352.25. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the company earned $5.90 earnings per share. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is 12.02%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- Expert Stock Trading Psychology Tips
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- How to Read Stock Charts for Beginners
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- 5 Top Rated Dividend Stocks to Consider
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.